Haemonetics (HAE) FCF Margin Growth (3y) (2012 - 2026)
Haemonetics (HAE) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 60.00 |
| 10 | Haemonetics | 4.91 Bn | 4.69 Bn | 202.80 Mn | 942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 942.00 |
| Mar 28, 2026 | 1,980.00 |
| Dec 27, 2025 | 1,015.00 |
| Sep 27, 2025 | 1,531.00 |
| Jun 28, 2025 | 557.00 |
| Mar 29, 2025 | 1,810.00 |
| Dec 28, 2024 | -366.00 |
| Sep 28, 2024 | 196.00 |
| Jun 29, 2024 | -301.00 |
| Mar 30, 2024 | 2,120.00 |
| Dec 30, 2023 | -2,820.00 |
| Sep 30, 2023 | 1,835.00 |
| Jul 1, 2023 | 156.00 |
| Apr 1, 2023 | -1,941.00 |
| Dec 31, 2022 | -716.00 |
| Oct 1, 2022 | 908.00 |
| Jul 2, 2022 | 103.00 |
| Apr 2, 2022 | 965.00 |
| Jan 1, 2022 | 208.00 |
| Oct 2, 2021 | 577.00 |